TrialJournal of substance use and addiction treatment2024

Buprenorphine-naloxone vs. extended-release naltrexone for opioid use disorder in individuals with and without criminal legal involvement: A secondary analysis of the X:BOT randomized controlled trial.

Dylan Rose Balter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.